For the past two months, we focused on US Healthcare and the European Healthcare systems. This month we are explored China’s Healthcare system by diving deep into the intricacies of government schemes, regulatory reforms, and trends and practices. In 2023, China spent around 5.4% of its GDP to boost healthcare services across its provinces. In…
Do you know that several European countries offer European Health Insurance Cards that allow citizens to seek emergency care when they travel? European countries are widely regarded for their superior quality healthcare services. With most European countries offering Universal Coverage for primary care, this magazine aims to navigate the nuances of the European Healthcare System. …
It’s an indubitable fact that the US sits at the top of the Biopharma industry. For the US, there is no limit to the innovation, discovery, or outsourcing of manufacturing and research facilities with their next-generation flexible manufacturing offered by numerous CDMOs and CROs. In 2023, the US government allocated 16.5 % of its GDP…
In June, PharmaShots was busy covering the heavy influx of life science updates. Our most-read Top 20 reports covered Nutraceutical and Innovative Digital Therapeutics companies. For the Disease of the Month report, we covered Fabry Disease. The Know Your Investor report featured a condensed report on Google Ventures. Like every Month, we published reports on Biosimilars, Designations, FDAand EMA approvals. In August, PharmaShots will…
May had been a busy month for PharmaShots with an unceasing influx of life science updates. In our most-read Top 20 section, we published reports on Diagnostic Companies and Medical Device Companies. Like every month, PharmaShots published reports on Key Biosimilars Events, FDA approvals, and EMA approvals along with the New Drug Designation Report. In the Disease of the Month report, we explored Sjögren’s…
Throughout April PharmaShots was swamped with the heavy traffic of life science updates. As an official media partner to Reuters Events, PharmaShots was present in Barcelona, covering groundbreaking presentations from leading biopharma companies. Our most-read top 20 section featured reports on Top 20 RNAi Therapeutic Companies, Top 20 Biopharma Deal Terminations of 2023, and Top 20 Biopharma Companies. For…
For the December Edition, PharmaShots magazine navigated Digital Biomarkers as a theme. Digital biomarkers are physiological and behavioral data gathered by wearables, ingestible devices, and implants. By harnessing and assessing digital biomarkers, healthcare researchers can predict the early onset of diseases, check disease progressions, and study lifestyle’s impact on health in general.Our curated sections…
Health is not a commodity, it’s an indispensable human right that must know no boundary of gender, race, or socio-economic status. Health for all is an all-inclusive mission by the WHO that aims to reduce preventable mortalities and morbidities by providing healthcare provisions in every area.Women health is still a concerning topic in under-developed and…
An applied study that assesses system-based solutions to make healthcare facilities accessible, equitable, and affordable for everyone. In simple words, healthcare economics studies the economic behavior of healthcare stakeholders (patients, providers, and biopharma companies among others)Inflation in the healthcare sector remains a major focus area for policymakers, practitioners, and healthcare economists. Our curated…
Immunization is an undeniable human right and an essential component of the healthcare industry that helps prevent more than 4M deaths annually from vaccine-preventable diseases like diphtheria, tetanus, measles, and influenza. With immunization as the theme, PharmaShots will be your guide to this healthcare excursion navigating the theme of immunization with a holistic approach.What…

